XOStem, Inc Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
XOStem, Inc. is a biotechnology research company based in Irvine, California, with a small team focused on translational biochemistry and stem cell science. It is developing therapies for Type 1 Diabetes, including a bioscience device that houses insulin-producing cells protected by encapsulation to shield them from autoimmune attack, with the goal of reducing the need for injections. The organization relies on partnerships with scientific institutions and university validation to advance novel therapies toward market, and it intends to broaden its work into companion animals (Dogs and Cats) before pursuing human applications, pending data. In parallel, XOStem is pursuing engineered exosome programs for regenerative applications, such as skin and joint care, with research focused on isolation, purity, and characterization to support product development. These engineered exosomes are designed to carry defined payloads to improve treatment outcomes as research progresses, aligning with its translational focus and collaborative approach.